Report Detail
Global Exosome Diagnostics and Therapeutics Market Growth (Status and Outlook) 2019-2024
- RnM3145459 |
- 19 March, 2019 |
- Global |
- 115 Pages |
- LPI(LP Information) |
- Other
Exosomes play a key role in facilitating cell-to-cell communication in the cancer prognosis. It suppresses the immune function by inducing apoptosis of activated cytotoxic T cells, which enable tumor progression in the human body.
According to this study, over the next five years the Exosome Diagnostics and Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Exosome Diagnostics and Therapeutics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Exosome Diagnostics and Therapeutics market by product type, application, key companies and key regions.
This study considers the Exosome Diagnostics and Therapeutics value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Instrument
Reagent
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Diagnostic
Therapeutic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Aethlon Medical(US)
Exosome Diagnostics(US)
NanoSomix Inc.(US)
Thermo Fisher Scientific (US)
Malvern Instruments (UK)
System Biosciences(US)
NX Pharmagen (US)
Sistemic Inc(UK)
Capricor Therapeutics (US)
Exiqon A/S (Denmark)
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Exosome Diagnostics and Therapeutics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Exosome Diagnostics and Therapeutics market by identifying its various subsegments.
Focuses on the key global Exosome Diagnostics and Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Exosome Diagnostics and Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Exosome Diagnostics and Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Exosome Diagnostics and Therapeutics Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Exosome Diagnostics and Therapeutics Market Size 2014-2024
- 2.1.2 Exosome Diagnostics and Therapeutics Market Size CAGR by Region
- 2.2 Exosome Diagnostics and Therapeutics Segment by Type
- 2.2.1 Instrument
- 2.2.2 Reagent
- 2.2.3 Software
- 2.3 Exosome Diagnostics and Therapeutics Market Size by Type
- 2.3.1 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Exosome Diagnostics and Therapeutics Market Size Growth Rate by Type (2014-2019)
- 2.4 Exosome Diagnostics and Therapeutics Segment by Application
- 2.4.1 Diagnostic
- 2.4.2 Therapeutic
- 2.5 Exosome Diagnostics and Therapeutics Market Size by Application
- 2.5.1 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Exosome Diagnostics and Therapeutics Market Size Growth Rate by Application (2014-2019)
3 Global Exosome Diagnostics and Therapeutics by Players
- 3.1 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Players
- 3.1.1 Global Exosome Diagnostics and Therapeutics Market Size by Players (2017-2019)
- 3.1.2 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Players (2017-2019)
- 3.2 Global Exosome Diagnostics and Therapeutics Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Exosome Diagnostics and Therapeutics by Regions
- 4.1 Exosome Diagnostics and Therapeutics Market Size by Regions
- 4.2 Americas Exosome Diagnostics and Therapeutics Market Size Growth
- 4.3 APAC Exosome Diagnostics and Therapeutics Market Size Growth
- 4.4 Europe Exosome Diagnostics and Therapeutics Market Size Growth
- 4.5 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Growth
5 Americas
- 5.1 Americas Exosome Diagnostics and Therapeutics Market Size by Countries
- 5.2 Americas Exosome Diagnostics and Therapeutics Market Size by Type
- 5.3 Americas Exosome Diagnostics and Therapeutics Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Exosome Diagnostics and Therapeutics Market Size by Countries
- 6.2 APAC Exosome Diagnostics and Therapeutics Market Size by Type
- 6.3 APAC Exosome Diagnostics and Therapeutics Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Exosome Diagnostics and Therapeutics by Countries
- 7.2 Europe Exosome Diagnostics and Therapeutics Market Size by Type
- 7.3 Europe Exosome Diagnostics and Therapeutics Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Exosome Diagnostics and Therapeutics by Countries
- 8.2 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type
- 8.3 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Exosome Diagnostics and Therapeutics Market Forecast
- 10.1 Global Exosome Diagnostics and Therapeutics Market Size Forecast (2019-2024)
- 10.2 Global Exosome Diagnostics and Therapeutics Forecast by Regions
- 10.2.1 Global Exosome Diagnostics and Therapeutics Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Exosome Diagnostics and Therapeutics Forecast by Type
- 10.8 Global Exosome Diagnostics and Therapeutics Forecast by Application
11 Key Players Analysis
- 11.1 Aethlon Medical(US)
- 11.1.1 Company Details
- 11.1.2 Exosome Diagnostics and Therapeutics Product Offered
- 11.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Aethlon Medical(US) News
- 11.2 Exosome Diagnostics(US)
- 11.2.1 Company Details
- 11.2.2 Exosome Diagnostics and Therapeutics Product Offered
- 11.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Exosome Diagnostics(US) News
- 11.3 NanoSomix Inc.(US)
- 11.3.1 Company Details
- 11.3.2 Exosome Diagnostics and Therapeutics Product Offered
- 11.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 NanoSomix Inc.(US) News
- 11.4 Thermo Fisher Scientific (US)
- 11.4.1 Company Details
- 11.4.2 Exosome Diagnostics and Therapeutics Product Offered
- 11.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Thermo Fisher Scientific (US) News
- 11.5 Malvern Instruments (UK)
- 11.5.1 Company Details
- 11.5.2 Exosome Diagnostics and Therapeutics Product Offered
- 11.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Malvern Instruments (UK) News
- 11.6 System Biosciences(US)
- 11.6.1 Company Details
- 11.6.2 Exosome Diagnostics and Therapeutics Product Offered
- 11.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 System Biosciences(US) News
- 11.7 NX Pharmagen (US)
- 11.7.1 Company Details
- 11.7.2 Exosome Diagnostics and Therapeutics Product Offered
- 11.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 NX Pharmagen (US) News
- 11.8 Sistemic Inc(UK)
- 11.8.1 Company Details
- 11.8.2 Exosome Diagnostics and Therapeutics Product Offered
- 11.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Sistemic Inc(UK) News
- 11.9 Capricor Therapeutics (US)
- 11.9.1 Company Details
- 11.9.2 Exosome Diagnostics and Therapeutics Product Offered
- 11.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Capricor Therapeutics (US) News
- 11.10 Exiqon A/S (Denmark)
- 11.10.1 Company Details
- 11.10.2 Exosome Diagnostics and Therapeutics Product Offered
- 11.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Exiqon A/S (Denmark) News
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Exosome Diagnostics and Therapeutics . Industry analysis & Market Report on Exosome Diagnostics and Therapeutics is a syndicated market report, published as Global Exosome Diagnostics and Therapeutics Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Exosome Diagnostics and Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
